期刊文献+

蛋白质类手性固定相的研究进展及其在药物手性拆分中的应用 被引量:5

Research Progress of Protein-based Chiral Stationary Phases and Their Applications to Chiral Drug Resolution
原文传递
导出
摘要 手性药物的色谱拆分方法包括手性衍生化试剂法、手性流动相添加剂法和手性固定相法等。随着大量商品化手性固定相色谱柱的出现,手性固定相法以其快速、简便、高效的特点,迅速在药物手性拆分领域占据主导地位。蛋白质类手性固定相是应用最为广泛的手性固定相之一,它能够提供多种类型的相互作用力和手性识别位点,对不同类型的药物具有广泛的手性识别能力。本文综述了蛋白质类手性固定相的研究进展,及近3年其在药物手性拆分中的应用,讨论了各种固定相的性质特点、适用范围、影响药物手性拆分的因素以及色谱方法优化流程等。 Chromatographic resolution of chiral drugs includes three kinds of approaches, namely chiral derivatization approach, chiral mobile phase approach, and chiral stationary phase (CSP) approach. Along with the emerge of a large number of commercially available CSP columns, the CSP approach quickly dominates the field of chiral drug resolution, due to its various advantages of high speed, simplicity, and efficiency. Protein-based CSPs remain one of the most widely used CSPs, and exhibit enantioselectivity for a wide range of compounds because of multiple binding sites on the surface of chiral selectors and multiple binding interactions between chiral selectors and ligands. This review mainly focuses on the research progress of protein-based CSPs and their applications to chiral drug resolution in recent 3 years, with the emphasis on their enantioselective properties, application scope, the factors influencing drug resolution, and a chromatographic optimization scheme on these stationary phases.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2015年第10期1122-1130,共9页 Chinese Journal of Pharmaceuticals
关键词 手性固定相 蛋白质类手性固定相 手性药物 拆分 综述 chiral stationary phase (CSP) protein-based CSP chiral drug resolution review
  • 相关文献

参考文献3

二级参考文献21

  • 1Yi-Hong Tanga,b,1,Jun-Yan Wanga,1,Hai-Hong Hua,Tong-Wei Yaoa,Su Zenga,n aDepartment of Pharmaceutical Analysis and Drug Metabolism,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang 310058,People’s Republic of China bShanghai Institute of Technology,Shanghai 201418,People’s Republic of China.Analysis of species-dependent hydrolysis and protein binding of esmolol enantiomers[J].Journal of Pharmaceutical Analysis,2012,2(3):220-225. 被引量:3
  • 2Shi-ping MA,Lei-ming REN,Ding ZHAO,Zhong-ning ZHU,Miao WANG,Hai-gang LU,Li-hua DUAN.Chiral selective effects of doxazosin enantiomers on blood pressure and urinary bladder pressure in anesthetized rats[J].Acta Pharmacologica Sinica,2006,27(11):1423-1430. 被引量:12
  • 3卢海刚,刘丽芳,任雷鸣,赵庆华,段丽华,张晓媛.多沙唑嗪对映体对兔四种血管α受体的作用[J].药学学报,2007,42(2):145-151. 被引量:9
  • 4田河林,任雷鸣.多沙唑嗪对映体不同给药途径对豚鼠膀胱排尿功能的影响[J].中国药理学与毒理学杂志,2007,21(2):118-123. 被引量:4
  • 5W. Rooks, P. Maloney, D. Shott, et al., The analgesic and anti- inflammatory profile of ketorolac and its tromethamine salt, Drugs Exp. Clin. Res. 11 (1985) 479-492.
  • 6R. Kauffman, M. Lieh-Lai, H. Uy, et al., Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children, Clin. Pharmacol. Ther. 65 (1999) 382-388.
  • 7F. Jamali, F. Pasutto, C. Lemko, HPLC of ketorolac enantiomers and application to pharmacokinetics in the rat, J. Liq. Chroma- togr. C.T. 12 (1989) 1835-1850.
  • 8A. Guzman, F. Yuste, R. Toscana, et al., Absolute configuration of (-)-5-benzoyl-1, 2-dihydro-3H-pyrrolo [1, 2-alpha] pyrrole- 1-carboxylic acid, the active enantiomer of ketorolac, J. Med. Chem. 29 (1986) 589 -591.
  • 9P. Hayball, J. Tamblyn, Y. Holden, et al., Stereoselective analysis of ketorolac in human plasma by high-performance liquid chromatography, Chirality 5 (1993) 31-35.
  • 10M. Vakily, B. Corrigan, F. Jamali, The problem of racemization in the stereospecific assay and pharmacokinetic evaluation of ketorolac in human and rats, Pharmacol. Res. 12 (1995) 1652-1657.

共引文献5

同被引文献56

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部